It has been a down day for UK equities on Wednesday with concern over Rachel Reeves’ future being seen as taking a toll on the main board, although the AIM All Share has been underwater all day – and (apologies, getting a bit political) many would be quick to argue that it would be difficult for a new chancellor to do any worse of a job than we have seen over the last year. The junior index closed down just over four points at 768.76.
- Thruvision +67%
- Mirriad Advertising +35%
- Acuity RM +18%
- Versarien -22%
- TAP Global -20%
Thruvision LON:THRU was up 67% on the day, following the announcement of a material award win this morning. Order intake for the quarter to 30th June was up 145%YoY and a management update on the cash position was that the company now appears funded through to the end of the year.
Mirriad Advertising LON:MIRI had another up day, adding 35%. There’s no news here and the stock remains deeply depressed from levels seen in the spring – we’ve seen sharply elevated levels of interest like this in recent weeks and it’s had no meaningful impact on the share price.
Acuity RM [LON:ACRM] gets the notable mention, up 18%. The company presented final results to investors today and that’s driven an elevated volume of trade, although transaction numbers are somewhat depressed.
Versarien LON:VRS was 22% lower, but that’s barely above the quoted spread. The stock was rattled by results last week and confidence still appears to be in short supply.
- AIM Market Roundup: Oracle Power, Versarien, EnergyPathways
- AIM Market Roundup: ImmuPharma, N4 Pharma, Versarien
TAP Global [LON:TAP] was 20% lower. The company made its AIM market debut last week following a migration from Aquis and it’s fair to say that it hasn’t been a great debut. This could however just be a case of the price settling and some investors making the most of higher levels of liquidity.
